Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Mitoxantrone + G-CSF in mHRPC
NCT00003183Phase 2Unknown
- Sponsor
- Hope Cancer Institute, Inc.
- Start
- Mar 1997
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of mitoxantrone in prostate cancer (PCa), sponsored by Hope Cancer Institute, Inc.. Status: unknown.
02
Drugs
mitoxantrone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003183.